McKinley Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

McKinley Capital Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-88,952	Closed	-$3.76M	–	371
2015 Q2	$3.76M	Sell	88,952 -142	-0.2%	-$5.99K	0.16%	159
2015 Q1	$3.46M	Sell	89,094 -9	-0%	-$347	0.14%	166
2014 Q4	$3M	Sell	89,103 -99,620	-53%	-$3.52M	0.12%	164
2014 Q3	$6.61M	Sell	188,723 -29	-0%	-$994	0.29%	93
2014 Q2	$6.2M	Sell	188,752 -1,111	-0.6%	-$38K	0.25%	99
2014 Q1	$7M	Sell	189,863 -33,107	-15%	-$1.21M	0.29%	83
2013 Q4	$8.56M	Sell	222,970 -42,067	-16%	-$1.33M	0.34%	74
2013 Q3	$7.26M	Buy	265,037 +306	+0.1%	+$7.25K	0.32%	78
2013 Q2	$5.56M	Buy	+264,731	New	+$5.17M	0.28%	80

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

McKinley Capital Management's WX Position: Q3 2015 in Review

McKinley Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 88,952 shares — an estimated $3.76M sold.

McKinley Capital Management first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $8.56M in Q4 2013. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

McKinley Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
McKinley Capital Management sold 88,952 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $3.76M.
McKinley Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
McKinley Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $8.56M in Q4 2013.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on McKinley Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.